Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

Clinical trial NCT00062751 · COMPLETED

Trial details

NCT number: NCT00062751
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2002-12-01
Primary completion: 2005-04-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.